ID: MRFR/HC/6335-HCR | 90 Pages | Published By Rahul Gotadki on March 2023
Gene Expression Analysis Market is expected to grow USD 7362.06 million at a 10.30% CAGR From 2020-2030.
Gene Expression Analysis Market Overview Gene Expression Analysis Market will show a steady growth rate in the forecast period. It will reach a valuation of USD 7362.06 million and register a CAGR of 10.30 % during the forecast period by 2030. Gene expression analysis is research for functional genomics to apply and study genes and gene transcripts. Synthesizing applicable gene products like functional RNAs and protein species will lead to intact organisms surviving when a gene goes missing. Growth in advanced medicine and technological developments is accelerating the market's growth. The growing development of genomic databases is a key growth factor, along with the increased rate of investment in genomics will fuel the market's growth. The cost reduction in sequencing will offer vast opportunities for stakeholders in the healthcare sector. For instance, affordable sequencing will enable researchers to sequence the genomes of thousands of individuals, which will lead to improved data for the identification of illnesses and their causes. This will also allow individuals with rare diseases to be treated immediately. Therefore, cost reduction of sequencing will be a major driver of the market.Active collaboration for the improvement of healthcare quality and the advancement in domestic biotechnology sectors, along with the rise of government funding for research, is the enhancing factors that provide huge growth opportunities to the industrial players of the gene expression analysis market.
The gene expression analysis market has been segmented into product, services, application, end-user, and region.
The market, on the basis of product, has been segmented into consumables and instruments.
The market, based on consumables, has been further segmented into reagents and DNA chips.
The market, based on instruments, has been further segmented into polymerase chain reaction (PCR), next-generation sequencing (NGS), microarray, Sanger sequencing, and others.
The market, by services, has been segmented into gene expression profiling services, sequencing services, bioinformatics solutions, and others.
The market, by application, has been segmented into drug discovery, diagnosis, research, and others.
The market, by end-user, has been segmented into pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations, and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The gene expression analysis market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European gene expression analysis market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The gene expression analysis market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The gene expression analysis market in the Middle East & Africa has been segmented into the Middle East and Africa.
GENERAL ELECTRIC COMPANY, Illumina, Inc., Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Pacific Biosciences of California, Inc., BGI, PerkinElmer Inc., Agilent Technologies, Inc., QIAGEN, Oxford Gene Technology, Eurofins Scientific, Danaher, Genotypic Technology Pvt Ltd, Macrogen Inc. are some of the key players in the global gene expression analysis market.
Regional Market Summary
Source: World Health Organization (WHO), Centers for Disease Control and Prevention (CDC)
Geographically, the Americas is anticipated to dominate the global gene expression analysis market owing to the increasing research activities and the rising popularity of gene expression tests. Additionally, the well-developed healthcare sector is anticipated to boost the American gene expression analysis market.
Europe is expected to hold the second largest position in the global gene expression analysis market. The market growth in this region is attributed to the availability of funds for research.
Asia-Pacific is anticipated to be the fastest growing region in the market due to the growing investment from governments in the field of genomics, and continuously developing economies. According to a report published by the International Journal of Social and Developmental Concerns in October 2017, in Malaysia, the growth of the public primary, as well as secondary care facilities, has decreased in the past few years, and it has not kept pace with the rapid urbanization. Thus, such factors restraint the growth of the market in this region. On the other hand, the Middle East & Africa has the least share of the market.
Global Gene Expression Analysis Market, by Product
Global Gene Expression Analysis Market, by Service
Global Gene Expression Analysis Market, by Application
Global Gene Expression Analysis Market, by End User
Global Gene Expression Analysis Market, by Region
Global Gene Expression Analysis Market, by Key Players
In May 2022
ODA Biotherapeutics, Inc., a biopharmaceutical company is developing a gene therapy chemogenetic platform for treating intractable neurological disorders, has announced that preclinical data from the Company's focal epilepsy program will be featured at the American Society of Gene & Cell Therapy 25th Annual Meeting being held virtually and in-person, May 16-19, 2022, in Washington, D.C.
CODA's approach for treating focal epilepsy is adeno-associated virus-mediated delivery of a novel engineered ligand-gated ion channel (LGIC) that can respond to an exogenous ligand. Oral administration of this small molecule ligand, which is designed to only interact with CODA's chimeric LGIC, is tuned to control the aberrant activity of neurons and suppress seizures.Intended Audience
|Market Size||USD 7362.06 million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Product, Services, Application, End-User and Region|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||GENERAL ELECTRIC COMPANY, Illumina, Inc., Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Pacific Biosciences of California, Inc., BGI, PerkinElmer Inc., Agilent Technologies, Inc., QIAGEN, Oxford Gene Technology, Eurofins Scientific, Danaher, Genotypic Technology Pvt Ltd, Macrogen Inc.|
|Key Market Opportunities||Research Activities|
|Key Market Drivers||Increasing research into genetics to understand the root causes of various diseases.|
The global gene expression analysis market is expected to rise to a valuation of USD 7326.06 million over the forecast period from 2020 to 2030.
The global market is expected to exhibit a stable 10.30% CAGR over the forecast period.
The increasing research into genetics to understand the root causes of various diseases is the major driver for the global gene expression analysis market.
North America is the leading regional market.
Leading players in the market include F. Hoffman-La Roche, Thermo Fisher Scientific, Macrogen, Illumina, and Danaher, among others.